Clinical Trial Update: A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas [Phase 1]

View source ↗

Summary

This Phase 1 pilot trial evaluated glioma-associated antigen vaccines with the Toll-like receptor 3 agonist Poly-ICLC in pediatric gliomas and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• High-grade Glioma
• Low-grade Glioma

Drugs mentioned

• Glioma-associated antigen vaccines
• Poly-ICLC (poly-ICLC)

Snippet

Sponsor: James Felker | Conditions: Newly Diagnosed Pediatric Pontine Glioma, Newly Diagnosed Pediatric High Grade Glioma | Phase 1 | Status: COMPLETED